|
| Study population (n = 62) | Complete short-termsuccess (n = 48) | Partial short-termsuccess (n = 12) | RFA failure (n = 2) | value |
|
hsTnI, ng/mL (normal range: <0.0156 for women; <0.0342 for man) | 0.053 (0.029–0.150) | 0.045 (0.024–0.161) | 0.052 (0.031–0.076) | 0.185 (0.079–0.290) | 0.493 |
CK-MB, ng/mL (normal range: <3.1) | 1.4 (0.9–2.6) | 1.4 (0.9–3.4) | 1.5 (1.1–1.6) | 1.3 (1.1–1.4) | 0.906 |
BNP before RFA, pg/mL (normal range: <159) | 261 (145–728) | 245 (133–482) | 458 (168–1273) | 526 (268–784) | 0.339 |
BNP at hospital discharge, pg/mL (normal range: <159) | 354 (176–495) | 262 (159–509) | 393 (369–495) | nd | 1.000 |
Creatinine, mg/dL (normal range: 0.55–1.02) | 1.17 (1.0–1.47) | 1.18 (1.03–1.46) | 1.08 (0.91–1.66) | 1.2 (1.15–1.26) | 0.894 |
Potassium, mmol/L (normal range: 3.5–5.1) | 4.3 (4.0–4.5) | 4.3 (4.0–4.5) | 4.5 (4.1–4.8) | 4.2 (4.2–4.2) | 0.603 |
CRP, mg/L (normal range: <5.0) | 3.4 (1.2–13.3) | 3.7 (1.3–12.7) | 2.2 (0.9–11.9) | 7 (0.6–13.9) | 0.782 |
Neutrophils × 109/L (normal range: 2.0–7.0) | 4.9 (3.6–6.6) | 5.1 (3.6–7.1) | 4.8 (3.5–5.4) | 5.5 (4.5–6.4) | 0.613 |
Lymphocytes × 109/L (normal range: 1.0–3.0) | 1.7 (1.2–2.3) | 1.7 (1.2–2.2) | 1.6 (0.9–2.5) | 1.9 (1.9–2.0) | 0.643 |
NLR (normal range: 1–3) | 3.1 (1.9–4.5) | 3.2 (1.9–4.5) | 2.7 (1.9–4.9) | 2.8 (2.3–3.4) | 0.815 |
Hemoglobin, g/dL (normal range: 12.0–15.0) | 13.4 (12.2–14.5) | 13.6 (12.3–14.5) | 12.6 (12.2–14.8) | 12.5 (11.6–13.3) | 0.574 |
Platelets × 109/l (normal range: 150–410) | 203 (172–241) | 213 (173–250) | 195 (174–206) | 155 (133–177) | 0.164 |
TSH, uU/mL (normal range: 0.35–4.94) | 1.7 (0.8–2.9) | 1.7 (0.8–2.9) | 1.5 (0.8–3.9) | 1.8 (1.8–1.9) | 0.961 |
FT4, pmol/L (normal range: 9.01-19.05) | 15.3 (13.4–16.4) | 15.2 (13.6–16.3) | 14.4 (12.0–16.7) | 17.4 (17.4–17.4) | 0.495 |
ALT, UL (normal range: 5–34) | 25 (19–37) | 27 (22–40) | 15 (14–24) | 187 (44–330) | 0.005 |
AST, U/L (normal range: <55) | 24 (18–29) | 25 (18–30) | 22 (17–23) | 39 (20–58) | 0.346 |
|